Stock listing

OTC:LADX LadRx Corporation Stock

Follow LadRx Corporation into a list and get an email when it puts out news.

Share price · OTC:LADX

$0.0003 USD 0.0000 (0.0%)

Close on Nov 20, 2026

Past year +50.0% · daily closes, Sep 24, 2026 – Nov 20, 2026, adjusted for splits
Day range
$0.0003 – $0.0003 USDNov 20, 2026
Volume
1,040 sharesNov 20, 2026
Market cap
—Left out: price × shares is far from the company's reported size
Traded on an average day
$0 USDMedian day 0 shares · 17 days with no trades · last 3 months, Sep 24, 2026 – Nov 20, 2026
LadRx Corporation logo

Daily closes

Last 3 months, Sep 24, 2026 – Nov 20, 2026 · OTC:LADX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00030.00000.0%$0.0003$0.0003$0.00031,040
$0.00030.00000.0%$0.0003$0.0003$0.00031,909
$0.00030.00000.0%$0.0003$0.0003$0.00033,003
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.0003+0.0001+50.0%$0.0003$0.0003$0.00031,176
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002342
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002——$0.0002$0.0002$0.0002140

Splits

4 splits since 1996 · OTC:LADX · every price before a split is adjusted for it

DayRatioWhat
1-for-100Consolidation
1-for-6Consolidation
1-for-7Consolidation
1-for-4Consolidation
Ticker
OTC:LADX
Asset type
Stock
Exchange
OTC
Currency
USD

LadRx Corporation on 6ix

Decks
7 decks · latest March 2025

Valuation

price Nov 20, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.06

Events

QuarterResults
Q1 2025May 13, 2025 · Before open
Q4 2024Mar 25, 2025 · Before open
Q3 2024Nov 12, 2024 · Before open
Q2 2024Aug 14, 2024 · Before open
Q1 2024May 15, 2024 · Before open
Q4 2023Mar 27, 2024 · Before open
Q3 2023Nov 14, 2023 · Before open
Q2 2023Aug 14, 2023 · Before open
Q1 2023May 15, 2023 · Before open
Q4 2022Mar 20, 2023 · Before open
All 17 quarters
QuarterResults
Q3 2022Nov 10, 2022 · Before open
Q2 2022Aug 11, 2022 · After close
Q1 2022Apr 1, 2022
Q3 2021Nov 11, 2021
Quarter to Jun 30, 2021Aug 24, 2021
Quarter to Mar 31, 2021May 13, 2021
Quarter to Dec 31, 2020Mar 26, 2021

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (March 2025)Investor deck20 slidesMarch 2025
Investor Presentation (June 2024)Investor deck20 slidesJune 2024
Investor Presentation (February 2024)Investor deck16 slidesFebruary 2024
Investor Presentation (July 2023)Investor deck16 slidesJuly 2023
Investor Presentation (January 2023)Investor deck20 slidesJanuary 2023
Investor Presentation (November 2022)Investor deck20 slidesNovember 2022
Investor Presentation (September 2022)Investor deck20 slidesSeptember 2022

Open Decks

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue000000250.0K
Research and development772.7K279.5K020.4K799.6K403.0K388.8K
Selling, general and administrative2.85M3.53M4.54M5.97M6.00M7.44M8.08M
Operating income-3.62M-3.82M-4.56M-5.98M-6.83M-7.86M-8.25M
Depreciation and amortization5.71K11.8K195.4K197.3K230.1K20.7K29.4K
EBITDA-3.62M-3.81M-4.36M-5.78M-6.60M-7.84M-8.22M
Interest expense01.72M
Income before tax-1.59M400.4K-4.20M-13.2M-6.70M-7.52M-9.08M
Income tax800800800
Net income-1.59M400.4K-4.20M-13.2M-6.70M-7.16M-12.7M
Earnings per share, basic-3.210.81-0.09-0.34-0.18-0.21-0.38

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents759.7K2.07M1.37M6.77M10.0M16.1M21.4M
Receivables0200.0K325.1K7.63K148.5K
Current assets837.0K2.26M2.00M8.28M11.4M17.2M22.5M
Property, plant and equipment235.3K430.0K620.2K42.9K44.3K
Goodwill0
Total assets839.5K2.31M2.25M8.73M12.1M17.3M22.9M
Accounts payable1.06M1.20M975.9K1.47M1.40M887.8K1.23M
Current liabilities2.26M2.20M2.19M3.73M2.77M2.05M2.56M
Total liabilities2.26M2.20M2.22M3.95M3.19M2.05M2.56M
Shareholders' equity-1.42M107.4K25.7K4.78M8.87M15.2M20.4M
Shares outstanding495.1K495.1K45.0M38.8M36.5M33.6M33.6M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2016FY2015
Cash from operations-1.31M1.01M-4.83M-12.3M-6.14M-5.72M-10.9M
Capital spending00-766-7.00K-25.9K-24.7K-11.5K00
Free cash flow-1.31M1.01M-4.83M-12.3M-6.17M-5.74M-10.9M
Cash from investing-766-7.00K-25.9K475.5K-11.5K
Cash from financing0-318.8K-561.4K9.08M39.0K39.0K-5.25M
Dividends paid0-68.8K-561.4K-171.7K-171.7K-171.7K-171.7K
Share buybacks0-250.0K0
Change in cash-1.31M695.1K-5.39M-3.23M-6.13M-5.24M-16.1M

Open Financials

Cap table

Built by 6ix from LadRx Corporation’s releases

Common shares
495,092
Fully diluted
495,092

Fully diluted

LineShares
Common shares495,092

Share count over time

CountShares
Nov 22, 2026495,092

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jennifer Simpson
Other companies: Eagle Pharmaceuticals, Inc. (Board Member, Lead Independent Director of the Board · Since at least Aug 28, 2019); Panbela Therapeutics, Inc. (President and CEO, Director · Mar 30, 2021 – Oct 1, 2024 · Past); Delcath Systems, Inc. (President and CEO, Director · Mar 23, 2012 – May 6, 2020 · Past)
Director · Jan 15, 2024 – Jan 15, 2024 · Past
Joel K CaldwellDirector · Jan 15, 2024 – Jan 15, 2024 · Past
John Y CalozChief Financial Officer · Jan 15, 2024 – Jan 15, 2024 · Past
Stephen SnowdyChief Executive Officer · Jan 15, 2024 – Jan 15, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about LadRx Corporation.